For instance, elevated ALT levels may serve as a more reliable indicator of NAFLD in men than in women, reflecting gender differences in liver enzyme activity and NAFLD pathophysiology. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.